APA (7th ed.) Citation

Yi, Z., Owusu-Edusei, K., Flem, E., Feemster, K., & Elbasha, E. H. (2026). Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis. Infectious Diseases & Therapy, 15(7), 1893. https://doi.org/10.1007/s40121-026-01364-x

Chicago Style (17th ed.) Citation

Yi, Zinan, Kwame Owusu-Edusei, Elmira Flem, Kristen Feemster, and Elamin H. Elbasha. "Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis." Infectious Diseases & Therapy 15, no. 7 (2026): 1893. https://doi.org/10.1007/s40121-026-01364-x.

MLA (9th ed.) Citation

Yi, Zinan, et al. "Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis." Infectious Diseases & Therapy, vol. 15, no. 7, 2026, p. 1893, https://doi.org/10.1007/s40121-026-01364-x.